Blueberries Medical Corp.
BBRRF
$0.009
-$0.0023-20.35%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 189.50K | 44.70K | 41.10K | 65.90K | 43.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 189.50K | 44.70K | 41.10K | 65.90K | 43.90K |
| Cost of Revenue | 131.70K | 9.20K | 31.10K | 50.00K | 7.30K |
| Gross Profit | 57.80K | 35.50K | 10.10K | 15.90K | 36.60K |
| SG&A Expenses | 171.10K | 182.20K | 172.10K | 184.70K | 302.80K |
| Depreciation & Amortization | 19.40K | 19.50K | 17.90K | 20.00K | 25.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 322.30K | 210.80K | 221.00K | 254.70K | 335.80K |
| Operating Income | -132.80K | -166.10K | -179.90K | -188.80K | -292.00K |
| Income Before Tax | -275.90K | -129.00K | -240.00K | -191.30K | -278.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -275.90K | -129.00K | -240.00K | -191.30K | -278.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -275.90K | -129.00K | -240.00K | -191.30K | -278.00K |
| EBIT | -132.80K | -166.10K | -179.90K | -188.80K | -292.00K |
| EBITDA | -113.30K | -146.70K | -162.00K | -168.80K | -267.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 399.03M | 399.03M | 399.03M | 399.03M | 222.27M |
| Average Diluted Shares Outstanding | 399.03M | 399.03M | 399.03M | 399.03M | 222.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |